Tango Therapeutics Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | -68.9% | +383.8% | -32.9% | +46.9% | +15.2% | +48.3% | |
| – | -95.0% | +21.0% | +104.9% | +2,759.9% | -97.8% | -8.7% | |
| – | – | +514.2% | -32.9% | +46.9% | +15.2% | +42.9% | |
| – | +54.9% | +55.3% | +36.4% | +8.8% | +24.9% | -8.2% | |
| – | +30.9% | +78.4% | +70.6% | +18.2% | +23.2% | -5.1% | |
| – | +672.6% | +63.5% | +42.7% | +10.9% | +24.5% | -8.7% | |
| – | – | – | – | – | – | – | |
| – | – | – | +157.8% | – | – | – | |
| – | – | – | – | – | – | – | |
| – | – | – | -81.5% | +148.1% | +55.2% | -98.1% | |
| – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.